Education, Science, Technology, Innovation and Life
Open Access
Sign In

A Prospective Observational Study on the Effect of Tetrandrine on the Progression of Pneumoconiosis Fibrosis

Download as PDF

DOI: 10.23977/medsc.2024.050321 | Downloads: 0 | Views: 42

Author(s)

Guangbo Zhang 1

Affiliation(s)

1 Occupational Diseases Hospital of Shandong First Medical University, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong Provinces, China

Corresponding Author

Guangbo Zhang

ABSTRACT

Pneumoconiosis is an occupational disease caused by long-term inhalation of dust particles, and the fibrosis process in the lungs is a critical stage of disease development, significantly affecting the patient's respiratory function and overall quality of life. Despite the existence of various treatment methods, the therapeutic effect of pneumoconiosis fibrosis is still unsatisfactory, and new treatment strategies are urgently needed to slow down or reverse the fibrosis process. This article first outlines the pathogenesis of pneumoconiosis fibrosis and the anti-fibrotic mechanism of tetrandrine, and then introduces the research design, experimental methods, and experimental process. Through prospective observational studies, this article systematically analyzed the intervention effect of tetrandrine on the progression of pulmonary fibrosis in patients with pneumoconiosis, and compared the changes in relevant indicators before and after treatment. The experimental results show that tetrandrine has shown good anti fibrotic effects in patients with pneumoconiosis. After a certain period of treatment, the degree of pulmonary fibrosis in patients has been significantly improved, and their respiratory function and quality of life have also been improved. Meanwhile, this article also observes that tetrandrine has a positive effect in regulating the levels of related inflammatory factors and cytkines, which helps to further slowdown or reverse the fibrosis process of pneumoconiosis.

KEYWORDS

Tetrandrine, Pneumoconiosis Fibrosis, Progression Observation, Prospective Research

CITE THIS PAPER

Guangbo Zhang, A Prospective Observational Study on the Effect of Tetrandrine on the Progression of Pneumoconiosis Fibrosis. MEDS Clinical Medicine (2024) Vol. 5: 136-144. DOI: http://dx.doi.org/10.23977/medsc.2024.050321.

REFERENCES

[1] Song M, Wang J, Sun Y, et al. Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages[J]. Acta Pharmacologica Sinica, 2022, 43(5): 1274-1284. 
[2] Ling M. Interpretation of Consensus of Chinese experts on pneumoconiosis treatment (2024)[J]. Journal of Environmental and Occupational Medicine, 2024, 41(1): 22-24.
[3] Lam M, Mansell A, Tate M D. Another one fights the dust: targeting the NLRP3 inflammasome for the treatment of silicosiss [J]. American journal of respiratory cell and molecular biology, 2022, 66(6): 601-611.
[4] Li J, Zhao H, Xie Y, et al. Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study[J]. Frontiers of Medicine, 2022, 16(5): 736-744.
[5] Qibin Du, Dongqing Wu, Yilian Tan, et al. Progress on pharmacological mechanism of active components of Chinese materia medica on silicosis[J]. Journal of Environmental and Occupational Medicine, 2023, 40(8): 981-988.
[6] Renchen X, Wang W, Lu Y. Emerging trends in silicosis research: a scientometric review[J]. Environmental Science and Pollution Research, 2023, 30(53): 113280-113296.
[7] Morin L, Lecureur V, Lescoat A. Results from omic approaches in rat or mouse models exposed to inhaled crystalline silica: a systematic review[J]. Particle and Fibre Toxicology, 2024, 21(1): 1-15.
[8] Tian X, Hou R, Liu X, et al. Yangqing Chenfei formula alleviates crystalline silica induced pulmonary inflammation and fibrosis by suppressing macrophage polarization[J]. Journal of Traditional Chinese Medicine, 2023, 43(6): 1126-1139.
[9] Liu G , Xing R , Zhu Z ,et al. Changes in serum protein expression in patients with pneumoconiosis fibrosis treated with Vernonia anthelmintica Willd injection[J].Asian journal of surgery, 2022, 45(6):1285-1286. 
[10] Wang Y .Research progress of ribonucleic acid m 6A methylation in respiratory diseases[J].Chemistry of Life, 2022, 42(3):483-490.
[11] Hua J T , Zell-Baran L , Go L H T ,et al.Response to: Correspondence on 'Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis' by Hoy et al[J].Occupational and environmental medicine, 2022, 79(12):849-850.
[12] Gülden. Sari, Koyuncu A, Imek C. Progressive Massive Fibrosis Risk Factors: A Retrospective Cross-Sectional Study [J].Journal of occupational and environmental medicine, 2022, 64(7):557-561. 
[13] Fried K W , Deleo P C .Demonstrating the protective effect of a 70-year-old occupational exposure limit against pneumoconiosis caused by mica:[J].Toxicology and Industrial Health, 2022, 38(2):63-69.
[14] Zeng Y, Jiang Y, Banks D E .The Effectiveness of Whole Lung Lavage in Pneumoconiosis: A Systematic Review and Meta-Analysis [J].Journal of occupational and environmental medicine, 2022, 64(8):e492-e499. 
[15] Bertke S J , Samet J , Sood A ,et al.Health burdens of uranium miners will extend beyond the radiation exposure compensation act deadline[J].Occupational and Environmental Medicine, 2022, 79(7):503-504.
[16] Uluer M E , Noble A .Influence of Mesh Design and Surface Treatments on Particle Transport and Fate in a Vibration-Enhanced Flooded Bed Dust Scrubber[J].Mining, Metallurgy & Exploration, 2024, 41(3):1245-1263.
[17] Barakat S E M , Alkhoofi F M .An abattoir study of pulmonary lesions in adult camels (Camelus dromedarius) from eastern region of Saudi Arabia[J]. Journal of Camel Practice and Research, 2023, 30(1):63-67.
[18] Lee E, Sim L L J. Silica health surveillance: a new approach[J].Occupational medicine (Oxford, England), 2022, 72(6):357-359.
[19] Yu S, Wang Y, Fan Y, et al. Pulmonary hypertension in patients with pneumoconiosis with progressive massive fibrosis [J]. Occupational and Environmental Medicine, 2022, 79(11): 723-728.

Downloads: 5195
Visits: 242910

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.